The new oral anticoagulants in atrial fibrillation: an update

por Verheugt, F. W. A.
Publicado 2013

Trials, registries and guidelines for non-ST-elevation acute coronary syndromes

por Verheugt, F. W. A.
Publicado 2013

Antiplatelet therapy with CABG: chaos in the Netherlands

por Verheugt, F. W. A.
Publicado 2017

Erratum to: Antiplatelet therapy with CABG: chaos in the Netherlands

por Verheugt, F. W. A.
Publicado 2017

The Global Anticoagulant Registry in the FIELD-Atrial Fibrillation (GARFIELD-AF): Exploring the changes in anticoagulant practice in patients with non-valvular atrial fibrillation...

por ten Cate, V., ten Cate, H., Verheugt, F. W. A.
Publicado 2016

Erratum to: The Global Anticoagulant Registry in the FIELD – Atrial Fibrillation (GARFIELD-AF): Exploring the changes in anticoagulant practice in patients with non-valvular atrial...

por ten Cate, V., ten Cate, H., Verheugt, F. W. A.
Publicado 2016

Massive Congenital Bidirectional Coronary Arteriovenous Malformation Presenting with Signs and Symptoms of Congestive Heart Failure in an Adult: A Case Report and Review of the Lit...

por Al Hashimi, H. M. M., Wardeh, A. J., Bulut, S., Verheugt, F. W. A.
Publicado 2011

Impact of the papillary muscles on cardiac magnetic resonance image analysis of important left ventricular parameters in hypertrophic cardiomyopathy

por Gommans, D.H.F., Bakker, J., Cramer, G.E., Verheugt, F.W.A., Brouwer, M.A., Kofflard, M.J.M.
Publicado 2016

P2Y12 blocker monotherapy after percutaneous coronary intervention

por Verheugt, F. W. A., Damman, P., Damen, S. A. J., Wykrzykowska, J. J., Woelders, E. C. I., van Geuns, R. -J. M.
Publicado 2021

Feasibility of TEE-guided stroke risk assessment in atrial fibrillation—background, aims, design and baseline data of the TIARA pilot study

por Dinh, T., Baur, L. H. B., Pisters, R., Kamp, O., Verheugt, F. W. A., Smeets, J. L. R. M., Cheriex, E. C., Tieleman, R. G., Prins, M. H., Crijns, H. J. G. M.
Publicado 2011

Gastrointestinal symptoms in low-dose aspirin users: a comparison between plain and buffered aspirin

por Jaspers Focks, J., Tielemans, M. M., van Rossum, L. G. M., Eikendal, T., Brouwer, M. A., Jansen, J. B. M. J., Laheij, R. J. F., Verheugt, F. W. A., van Oijen, M. G. H.
Publicado 2014

Changes in anticoagulant prescription in Dutch patients with recent-onset atrial fibrillation: observations from the GARFIELD-AF registry

por Seelig, J., Verheugt, F. W. A., Hemels, M. E. W., Illingworth, L., Lucassen, A., Adriaansen, H., Bongaerts, M. C. M., Pieterse, M., Herrman, J. P. R., Hoogslag, P., Hermans, W., Groenemeijer, B. E., Boersma, L. V. A., Pieper, K., ten Cate, H.
Publicado 2020

Impact of percutaneous coronary intervention timing on 5-year outcome in patients with non-ST-segment elevation acute coronary syndromes. The ‘wait a day’ approach might be safer...

por Oosterwerff, Erik F.J., Fagel, N. D., Slagboom, T., Tijssen, J. G. P., Herrman, J. P., Smits, P. C., Suttorp, M. J., Ronner, E., Laarman, G. J., Patterson, M. S., Amoroso, G., Vink, M. A., van der Schaaf, R. J., Verheugt, F. W. A., Riezebos, R. K.
Publicado 2016